Evidence map›Paper›PMID 31632903›Full record

ReviewFrontiers in oncology2019

Current Trends for Improving Safety of Stereotactic Brain Biopsies: Advanced Optical Methods for Vessel Avoidance and Tumor Detection.

Serik K Akshulakov, Talgat T Kerimbayev, Michael Y Biryuchkov, Yermek A Urunbayev, Dara S Farhadi, Vadim A Byvaltsev

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06263361 (Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma), which is not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06263361 recruitingnot on this mapstarted 2021, after this paper: background citation

Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma (PCNSL): Integration of Advanced MRI Patterns and Fluorescein Sodium Fluorescence

TypeobservationalSponsorIRCCS San RaffaeleRan2021 to 2029Enrolled15ConditionsCerebral LymphomaArmsMRI imaging, Cerebral biopsy
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Towards Optical Biopsy in Glioma Surgery.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Optical Brain Biopsy with a Fluorescence and Vessel Tracing Probe.Operative neurosurgery (Hagerstown, Md.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Serik K AkshulakovDepartment of Neurosurgery, JSC "National Center for Neurosurgery", Nur-Sultan, Kazakhstan.
Talgat T KerimbayevDepartment of Neurosurgery, JSC "National Center for Neurosurgery", Nur-Sultan, Kazakhstan.
Michael Y BiryuchkovDepartment of Neurosurgery and Traumatology, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan.
Yermek A UrunbayevDepartment of Neurosurgery, JSC "National Center for Neurosurgery", Nur-Sultan, Kazakhstan.
Dara S FarhadiUniversity of Arizona College of Medicine, Phoenix, AZ, United States.
Vadim A ByvaltsevDepartment of Neurosurgery, JSC "National Center for Neurosurgery", Nur-Sultan, Kazakhstan.
Irkutsk State Medical University · RUUniversity of Arizona · USWest Kazakhstan Marat Ospanov State Medical University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stereotactic brain needle biopsies are indicated for deep-seated or multiple brain lesions and for patients with poor prognosis in whom the risks of resection outweigh the potential outcome benefits. The main goal of such procedures is not to improve the resection extent but to safely acquire viable tissue representative of the lesion for further comprehensive histological, immunohistochemical, and molecular analyses. Herein, we review advanced optical techniques for improvement of safety and efficacy of stereotactic needle biopsy procedures. These technologies are aimed at three main areas of improvement: (1) avoidance of vessel injury, (2) guidance for biopsy acquisition of the viable diagnostic tissue, and (3) methods for rapid intraoperative assessment of stereotactic biopsy specimens. The recent technological developments in stereotactic biopsy probe design include the incorporation of fluorescence imaging, spectroscopy, and label-free imaging techniques. The future advancements of stereotactic biopsy procedures in neuro-oncology include the incorporation of optical probes for real-time vessel detection along and around the biopsy needle trajectory and

Indexed as

5-aminolevulinic acidbiopsyfluorescein sodiumfluorescenceopticalspectroscopystereotactic

Identifiers

PMID31632903
PMCPMC6783564
OpenAlexW2977778156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.